16:09 EST Nektar (NKTR) files automatic mixed securities shelf
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NKTR:
- Nektar Therapeutics Reveals Promising Phase 2b Trial Results
- Nektar presents new data from REZOLVE-AD study of ACAAI
- Nektar Therapeutics’ Earnings Call Highlights Robust Growth and Innovation
- Nektar Therapeutics Reports Q3 2025 Financial Results
- Hold Rating on Nektar Therapeutics Amid Uncertainties in Rezpeg’s Clinical Trials and Market Potential